GKOS Stock Surges Following Q3 Earnings & Revenue Beat, Guidance RaisedZacks Investment Research • 10/30/25
Will Glaukos (GKOS) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 10/22/25
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual MeetingBusiness Wire • 10/14/25
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29Business Wire • 10/08/25
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, AlabamaBusiness Wire • 09/25/25
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance RaisedZacks Investment Research • 07/31/25
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement RisksZacks Investment Research • 07/09/25
Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30Business Wire • 07/09/25
Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS TherapiesBusiness Wire • 06/25/25
Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 06/11/25
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins DeclineZacks Investment Research • 05/01/25